drugset / Trial / NCT01284868
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
RandomizedCrossoverSingle-blindBasic science
Summary
To explore what is driving heart-rate increases after dosing with mirabegron. Subjects will be given a beta-blocker at the same time as mirabegron.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bisoprolol | Other / unclassified | — | Oral |
| Subject | Mirabegron | Other / unclassified | — | Oral |
| Subject | Propranolol | Small molecule | — | Oral |
Indications
No indication recorded.